Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.615 USD | +8.06% |
|
+10.68% | -70.53% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.53% | 25Cr | |
+2.88% | 9.4TCr | |
+6.58% | 4.16TCr | |
-13.64% | 3.33TCr | |
+77.12% | 2.88TCr | |
-16.20% | 1.56TCr | |
-7.85% | 1.33TCr | |
-12.49% | 1.15TCr | |
+166.50% | 1.01TCr | |
-54.80% | 909.28Cr |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- HC Wainwright Adjusts Price Target on Revance Therapeutics to $41 From $48, Maintains Buy Rating